Glaukos (GKOS) Interest Coverage Ratio Growth (1y) (2015 - 2026)
Glaukos (GKOS) Interest Coverage Ratio Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -45.18% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 59.82% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -80.85% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 11.06% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 189.50% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -6.18% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -54.61% |
| 10 | Glaukos | 8.79 Bn | 8.68 Bn | 117.23 Mn | 81.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.55% |
| Dec 31, 2025 | -862.38% |
| Sep 30, 2025 | 87.34% |
| Jun 30, 2025 | 85.73% |
| Mar 31, 2025 | 46.68% |
| Dec 31, 2024 | 47.54% |
| Sep 30, 2024 | -194.22% |
| Jun 30, 2024 | -244.50% |
| Mar 31, 2024 | -299.14% |
| Dec 31, 2023 | -251.30% |
| Sep 30, 2023 | -68.72% |
| Jun 30, 2023 | -2.96% |
| Mar 31, 2023 | -538.61% |
| Dec 31, 2022 | -89.62% |
| Sep 30, 2022 | -341.50% |
| Jun 30, 2022 | 40.05% |
| Mar 31, 2022 | 202.19% |
| Dec 31, 2021 | -159.28% |
| Sep 30, 2021 | 118.72% |
| Mar 31, 2021 | 73.34% |